n.cardoso
TL2 · Ghent
Contributes reviews on supplier material. Based in Ghent.
Joined 13 April 2025 · last posted 5d
73 posts, newest first. Showing up to 150.
-
Aggregate verification data across the directory, with caveats Replied, post #65 · Sourcing › Independent verification · 23 Jul 2026 · 0 likes My experience of aggregate verification data contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's experience…
-
Batch numbers that do not match the vial label Replied, post #47 · Sourcing › Red flags · 22 Jul 2026 · 2 likes Worth separating two things that post #45 runs together. Reporting something here requires the batch, the date, the method and the document, which is exactly what makes…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #99 · Analytics › Impurities & related substances · 21 Jul 2026 · 26 likes Truncation products: fragments from incomplete synthesis or from degradation. They elute quite differently from the intact peptide because they are much smaller and…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #108 · Sourcing › Independent verification · 20 Jul 2026 · 1 like Post #107 answers the question as asked. The question underneath it is different. On Interpreting a result: the maintained page in the documentation commons covers the…
-
Substitution between formats during a shortage — what changed since Replied, post #19 · Access › Shortages · 18 Jul 2026 · 16 likes Post #16 is the version of this I will quote in future. One addition. Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and resuming…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #76 · Evidence › Journal club · 17 Jul 2026 · 1 like Building on post #73 rather than restating it. The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells…
-
Request: a per-category review queue Replied, post #109 · Meta › Feature requests · 17 Jul 2026 · 15 likes Post #107 is the version of this I will quote in future. One addition. Adding a null result on per-category review queue. I looked, carefully, and found nothing, and…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #116 · Evidence › Journal club · 13 Jul 2026 · 0 likes Post #113 is the version of this I will quote in future. One addition. Indirect comparison is well covered in the tag pages, and the older discussions are better than…
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #81 · Analytics › Method validation · 7 Jul 2026 · 0 likes This follows post #78 rather than contradicting it. Robustness: the method gives consistent results when minor parameters vary. Tested by deliberately varying pH,…
-
Aggregate verification data across the directory, with caveats Replied, post #25 · Sourcing › Independent verification · 3 Jul 2026 · 0 likes I would rather this thread reach "we do not know" about aggregate verification data than reach a confident answer that nobody can support when asked.
-
What I would want from a home test that does not exist yet — what changed since Replied, post #73 · Analytics › Home & field testing · 29 Jun 2026 · 0 likes Nothing to add, except that this is the answer I would give if asked.
-
About the HPLC & UHPLC category Replied, post #4 · Analytics › HPLC & UHPLC · 23 Jun 2026 · 25 likes Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
-
The anatomy of a question that gets answered within an hour Replied, post #84 · Start Here › How to Ask · 20 Jun 2026 · 0 likes Post #81 is the version of this I will quote in future. One addition. A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the…
-
Alcohol: what is documented and what is folklore Replied, post #65 · Practice › Interactions · 19 Jun 2026 · 6 likes Adding a note of thanks rather than an opinion. I did not know most of that.
-
Rewriting my first post: a before-and-after, with commentary — what changed since Replied, post #8 · Start Here › How to Ask · 17 Jun 2026 · 16 likes I had written a reply contradicting post #6 and deleted it. Here is what survived. Tag your own topic. Two accurate tags do more for how findable it is than a long…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #117 · Practice › Interactions · 2 Jun 2026 · 6 likes Post #115 answers the question as asked. The question underneath it is different. The most defensible general position in this subcategory: identify the plausible…
-
Does a peptide degrade silently, with no visual change? Replied, post #37 · Practice › Storage & stability · 30 May 2026 · 14 likes Adding the measurement that post #36 says would settle it. Adding what did not work for me on peptide, since the failures never get written up and they are half the…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #57 · Evidence › Preprints · 19 May 2026 · 12 likes Where numbers change between preprint and published version, the changes are not random. They tend toward a smaller effect and a more carefully hedged claim. Two people…
-
Injection volume, overload, and peak distortion Replied, post #11 · Analytics › HPLC & UHPLC · 18 May 2026 · 0 likes Method validation is the demonstration that a method can separate the compound from its degradation products and impurities reliably. A method that cannot resolve an…
-
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #29 · Clinical › Comorbidities · 17 May 2026 · 0 likes Nothing here is medical advice and clinicians posting in this subcategory say so on their own account rather than because a rule requires it. Scoping that to what I…
-
Follow-up: Search filters: what is missing Replied, post #103 · Meta › Site feedback · 16 May 2026 · 12 likes Where the Search filters discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same sentence…
-
Alcohol: what is documented and what is folklore Replied, post #4 · Practice › Interactions · 6 May 2026 · 3 likes Answering the question post #2 raises rather than the one it answers. If you are new and reading this thread for the answer to alcohol: the answer is conditional, the…
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #87 · Research Methods › Statistics · 25 Apr 2026 · 16 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
-
Run-in periods and the population they select Replied, post #101 · Evidence › Trials · 17 Apr 2026 · 18 likes Entry criteria, run-in periods and the self-selection of people willing to enter a multi-year trial all narrow the population. That is how internal validity is bought…
-
Type 2 diabetes and the largest part of the evidence base Replied, post #36 · Clinical › Comorbidities · 19 Mar 2026 · 0 likes That is the distinction I keep failing to hold on to. Written down now.
-
Reconstitution volumes that produce round numbers, tabulated Replied, post #56 · Practice › Reconstitution · 1 Mar 2026 · 14 likes Post #54 put the caveat in the right place and I want to underline it. Preservative effectiveness is tested against a defined microbial challenge under defined…
-
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #30 · Analytics › Impurities & related substances · 24 Feb 2026 · 11 likes Good question, well framed, and I would like to see it answered properly.
-
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #12 · Analytics › Impurities & related substances · 10 Feb 2026 · 9 likes Racemisation produces a diastereomer that is mass-identical and chromatographically resolvable only on a method chosen for the purpose. Standard reversed-phase…
-
Coming back to: Reconstitution volumes that produce round numbers, tabulated Replied, post #3 · Practice › Reconstitution · 9 Feb 2026 · 22 likes Post #2 is right about the mechanism and I think understates the practical bit. Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #104 · Sourcing › Independent verification · 1 Feb 2026 · 1 like Repeat determination on the same product line months apart is the measurement that speaks to consistency, and consistency is what most buyers actually want.
-
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #42 · Sourcing › Red flags · 8 Jan 2026 · 0 likes Where somebody posts a concern, ask what would resolve it before arguing about it. Half of these threads end with a document nobody had asked for. I am confident about…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #72 · Practice › Side effects · 29 Dec 2025 · 0 likes Adding the measurement that post #71 says would settle it. The published rates come from populations that were titrated on a defined schedule with clinical supervision.…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #90 · Analytics › Home & field testing · 28 Dec 2025 · 0 likes Post #88 describes the usual case. This is about the unusual one. Where home testing is genuinely valuable is as a screen before spending on independent analysis, not…
-
Tirzepatide's shorter half-life and its one practical consequence Replied, post #17 · Compounds › Tirzepatide · 30 Nov 2025 · 1 like Gastrointestinal effects were comparable in character to the GLP-1 monoagonists across the programme. Individual reports here vary in both directions, which is what you…
-
Dead volume across syringe and needle combinations Replied, post #28 · Devices › Syringes & needles · 23 Nov 2025 · 18 likes A definition problem is doing most of the work in this dead volume across syringe discussion. Once the term is pinned down I suspect the disagreement mostly goes away…
-
Pooling trials with different estimands — what changed since Replied, post #53 · Evidence › Meta-analyses · 19 Nov 2025 · 4 likes Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be…
-
Robustness: the parameters worth deliberately varying Replied, post #6 · Analytics › Method validation · 17 Nov 2025 · 12 likes Post #5 is right about the mechanism and I think understates the practical bit. Robustness: the method gives consistent results when minor parameters vary. Tested by…
-
EMA product information as a primary source Replied, post #59 · Regional › European Union · 12 Nov 2025 · 0 likes A device-and-compound combination has one authorisation and two supply chains, and the device is more often the limiting one. I would put the burden of proof on the…
-
Revisiting: Aggregates and why a purity assay may miss them entirely Replied, post #2 · Analytics › Impurities & related substances · 11 Nov 2025 · 0 likes The honest reading of a purity figure: it is an upper bound on how much of what the method could see was the intended species, under one integration convention, on one…
-
[2026 update] Long-time reader, first-time poster Replied, post #20 · Lounge › Introductions · 25 Oct 2025 · 11 likes A note on scope: what I am saying about Long-time reader applies to the case in the first post and I would not extend it further without checking.
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #14 · Compounds › Oral incretins · 22 Oct 2025 · 0 likes Oral bioavailability is variable between people. Some people absorb well; others absorb poorly. That inter-individual variation is larger than with injectables and is…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #149 · Practice › Reconstitution · 21 Oct 2025 · 0 likes Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe at that concentration, 100 units = 1 mL = 2.5 mg, so…
-
Compounds this community declines to help with, and why Replied, post #74 · Compounds › Other compounds · 6 Oct 2025 · 3 likes Why catalogue breadth is not evidence of anything: a supplier listing 500 compounds does not make the 450 untested ones likely to work. It makes them untested compounds…
-
Availability by country, dated, with primary sources Replied, post #10 · Access › International · 4 Oct 2025 · 25 likes Regional stock in your own country removes the border question entirely, which is the reason it changes the calculation rather than just the timing. Marking that as an…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #31 · Compounds › Cagrilintide & amylin analogues · 2 Oct 2025 · 10 likes On dosing intervals: the long-acting design supports weekly administration, and the escalation schedules in the published trials are gentler than the compound's potency…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #34 · Practice › Administration · 26 Aug 2025 · 15 likes No disagreement from me. Posting only so the question does not look ignored.
-
A ten-fold dose error caught before injection — one year on Replied, post #98 · Devices › Syringes & needles · 4 Aug 2025 · 3 likes Post #96 is right about the mechanism and I think understates the practical bit. Reading units correctly: look at the marking from the side, not from above or below.…
-
Coming back to: Sample size calculations, read backwards from the published number Replied, post #61 · Evidence › Trials · 23 Jul 2025 · 0 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
-
A field-by-field walk through a certificate of analysis Replied, post #37 · Analytics › COA interpretation · 15 Jul 2025 · 4 likes Post #36 and I disagree about the size of the effect, not about the direction. Practical note on field-by-field walk through a certificate: write down what you expect…
-
Criticising the method without criticising the authors — one year on Replied, post #10 · Evidence › Study critique · 7 Jul 2025 · 0 likes I had written a reply contradicting post #8 and deleted it. Here is what survived. Criticise the method, not the author: a paper with a weak design is not a bad paper…
-
Request: a diff view for wiki revisions — the long version Replied, post #16 · Meta › Feature requests · 6 Jul 2025 · 11 likes Small request: let me filter Latest by whether I have read the topic. Unread exists as a tab and does not combine with anything else, so a busy category is either all…
-
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #65 · Evidence › Journal club · 3 Jul 2025 · 0 likes Where the CagriSema phase 2 combination paper discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #68 · Compounds › Retatrutide · 21 Jun 2025 · 0 likes Everything in post #65 holds. The case it does not cover is the one I have. What I can speak to on Triple agonism is narrow, so I will keep it narrow rather than…
-
What this community means by "a source", in practical terms Replied, post #11 · Start Here › Welcome · 20 Jun 2025 · 0 likes Reading the guidelines before you post is genuinely worth the twenty minutes. Not because you will break one, but because the rules explain why the place reads the way…
-
Coming back to: Getting a referral rather than a refusal Replied, post #27 · Clinical › Prescriber conversations · 3 Jun 2025 · 28 likes Post #26 is the version of this I will quote in future. One addition. Bringing a published document rather than a summary changes the conversation. Bringing a forum…
-
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #14 · Practice › Dosing & titration · 19 May 2025 · 14 likes Post #11 put the caveat in the right place and I want to underline it. If symptoms reset at each step, that is the expected pattern rather than a sign that the previous…
-
Water content on a certificate and why it changes the arithmetic Replied, post #9 · Analytics › COA interpretation · 30 Apr 2025 · 2 likes Worth separating two things that post #7 runs together. A certificate of analysis is a statement by its issuer that a defined test was performed on a defined lot and…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #115 · Compounds › Semaglutide · 24 Mar 2025 · 0 likes Adding thanks rather than a view. I do not have a view worth the space.
-
Why a pen's dose steps are fixed and what that costs you — one year on Replied, post #5 · Devices › Pens & autoinjectors · 14 Mar 2025 · 5 likes This is the sort of exchange that makes the archive worth searching.
-
Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #18 · Evidence › Journal club · 1 Mar 2025 · 4 likes SURMOUNT-OSA would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #56 · Compounds › Semaglutide · 9 Feb 2025 · 0 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Started this topic · Evidence › Meta-analyses · 23 Jan 2025 · 1 like On the subject in the title: Random versus fixed effects: choosing rather than defaulting — a second dataset Working notes rather than a conclusion. Posting a small…
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #30 · Analytics › COA interpretation · 20 Jan 2025 · 11 likes Building on post #27 rather than restating it. A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to…
-
Follow-up: Individual participant data versus aggregate data Replied, post #24 · Evidence › Meta-analyses · 8 Jan 2025 · 1 like Reading rather than contributing, but this is the most useful thread I have found on it.
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #36 · Practice › Reconstitution · 5 Dec 2024 · 30 likes Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all of them, writing the concentration on each vial in…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #114 · Clinical › Prescriber conversations · 3 Dec 2024 · 15 likes A pharmacist can answer a great many of the questions people save for a prescriber, faster and often better, particularly about interactions and formulations.
-
How to ask for a dose change without antagonising anyone — what changed since Replied, post #80 · Clinical › Prescriber conversations · 20 Nov 2024 · 5 likes Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation.
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #99 · Practice › Dosing & titration · 7 Nov 2024 · 16 likes If you are stepping up mainly because the schedule says so rather than because the current dose has stopped doing what you wanted, that is worth noticing before rather…
-
Choosing which test to pay for, given a fixed budget — does this still hold? Replied, post #5 · Sourcing › Independent verification · 21 Oct 2024 · 3 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
-
Follow-up: Oral contraceptives and delayed emptying: what the data shows Replied, post #7 · Practice › Interactions · 22 Jul 2024 · 20 likes I think the Oral contraceptives and delayed emptying question is answerable and has not been answered, which is a more optimistic position than most of this thread.
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #125 · Practice › Dosing & titration · 10 Jul 2024 · 10 likes Answering the question post #124 raises rather than the one it answers. Dose and effect are not linear across the studied range for every compound in this class.…
-
Two sessions a week versus four: what the evidence supports — a second dataset Replied, post #26 · Nutrition & Training › Resistance training · 6 Jul 2024 · 6 likes Anybody returning after a break should expect to start lower than they left, and expecting otherwise is where injuries come from. If this contradicts something…
-
Assessing a warm arrival: the decision process — one year on Replied, post #58 · Sourcing › Logistics · 30 May 2024 · 0 likes Posting my Assessing a warm arrival numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who wanted a…